Drs. Maron and Rowin focus on modern treatment options for patients with symptomatic obstructive hypertrophic cardiomyopathy, including both new medications and long-established invasive procedures that relieve heart obstruction and improve symptoms. They emphasize that multiple effective choices now exist, and that factors like patient preference, access to drugs, and other heart conditions help determine the best approach.